Navigation Links
Precancerous Lesions Raise Cervical Cancer Risk
Date:10/26/2007

Study finding may lead to changes in recommendations for Pap tests

FRIDAY, Oct. 26 (HealthDay News) -- Women who have had advanced precancerous lesions of the cervix are still at risk for invasive cancers up to 25 years later, Swedish researchers report.

Currently, the American Cancer Society recommends that women who have had precancerous lesions called severe dysplasia/carcinoma in situ (CIS) continue getting Pap tests for 10 years after treatment. But, based on this study, these guidelines may need to be changed, said Debbie Saslow, the society's director of breast and gynecologic cancer, who was not involved with the research.

Saslow added, however, that even though these women continue to be at risk for developing cervical or vaginal cancer, the risk is low. "Women who have been treated for advanced precancer do need to remain vigilant," she said.

"This paper is going in my file for when we update our guidelines in the next two years," Saslow added. "We will see if we want to stick with 10 years or go to a much wider interval."

The study was led by Dr. Bjorn Strander, a senior consultant with the Department of Obstetrics and Gynecology at Sahlgren's Academy at the University of Gothenburg. The researchers collected data on 132,493 women who had a diagnosis of severe dysplasia/CIS between 1958 and 2002. The statistics came from the National Swedish Cancer Register.

The researchers found 881 women had developed cervical cancer, and 111 had developed vaginal cancer more than one year after the initial diagnosis. This was almost seven times higher than expected, the researchers said.

Women with a diagnosis of severe dysplasia/CIS were more than twice as likely to develop cancer compared with the general female population. The women were also twice as likely to develop invasive cervical cancer after diagnosis of CIS if that diagnosis was made between 1991 and 2000, compared with the sa
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. New Approach to Treating Precancerous Esophagus Condition
2. Precancerous Blood Donors Do Not Pass on the Disease
3. Identifying brain lesions with impaired consciousness
4. Leveling Lupus Lesions
5. The Link Between Migraine And Brain Lesions Questioned
6. Lesions in the eyes may forecast a stroke
7. Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People
8. Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People
9. Combination of Bronchoscopic Techniques is Very Effective for Lung Lesions
10. Obesity raises IVF miscarriage risk
11. Heavy Drinking Raises Risk of Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... The New Jersey Innovation Institute (NJII), acting ... Health, has received a $2.9 million grant from the Office of the National ... and Human Services (HHS). NJII will help the Department of Health ensure the ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor service ... personal-care device that makes it easy to apply lotion or medication to a hard-to-reach ... assistance when applying lotion or medication to the back, and provides thorough coverage. The ...
(Date:7/30/2015)... ORLEANS (PRWEB) , ... July 30, 2015 , ... Author ... and take charge of their health in his new self-help book, “ Consciously Healing ... Llanos’ new book promotes a simple message: “If we take responsibility for ourselves, we ...
(Date:7/30/2015)... ... , ... Summer is the dry eye season, especially in parts of the ... and hot 2015 summer season and the dry eye rate in the hot spots ... the 2015 summer season and identify the primary dry eye hot spots on her ...
(Date:7/30/2015)... ... July 30, 2015 , ... HEALTHCAREfirst , the leading ... announced today that it is hosting a free webinar detailing the 2016 proposed rule ... HEALTHCAREfirst Consultant and former Vice President of Regulatory Affairs for the National Association for ...
Breaking Medicine News(10 mins):Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2
... , NEW YORK, Dec. 10 SIRIUS ... Doctor Radio Reports: Kids and Video Games - What ... by journalist Perri Peltz on which she and a panel of experts ... effects they have on children. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) , ...
... , SALEM, Ore., Dec. 10 West Coast Bank,s ... Bears for children hospitalized at the Salem Hospital Pediatric Wing and ... Bears at the branch, 5686 Commercial St. SE, Suite 110 on ... BSN CPN, Nurse Manager of Pediatrics at Salem Hospital said, "The ...
... of alcoholic beverages (at least three to four drinks per ... a 30 percent increased risk of breast cancer recurrence, according ... may be most susceptible to the effects of alcohol on ... of this study will be presented December 9-13 at the ...
... to die or be disabled by midlife, study finds, , THURSDAY, ... a man,s risk of dying or becoming disabled by the time ... findings are from a study that began following 411 South London ... those who at age 10 displayed antisocial behavior (such as skipping ...
... ... leader in Sales and Operations Planning (S&OP) solutions, announced a program ... JDA The Steelwedge "i2 Exchange Program" address i2 customers that ... recently announced merger between i2 and JDA (formerly Manugistics), or are ...
... , RANCHO CORDOVA, Calif., Dec. 10 ThermoGenesis Corp. (Nasdaq: ... processing and storing adult stem cells, said today that Craig ... industry experience, has been named to the Company,s board of ... to six. , Moore is currently associated with several public ...
Cached Medicine News:Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy' 4Health News:Alcohol consumption may increase breast cancer recurrence risk 2Health News:Bad Behavior as a Kid Linked to Early Death in Men 2Health News:Leading Sales and Operations Planning (S&OP) Provider Steelwedge Announces i2 Exchange Program 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 2Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 3Health News:ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore to Board of Directors 4
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
(Date:7/30/2015)... Global ENT (Ear, Nose, ... USD 23.01 million in 2022, according to a new ... geriatric population, increasing prevalence of ear, nose, and throat ... among target customer base are expected serve this market ... According to estimates published by the WHO, 15% of ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... Findings Reinforce March of Dimes Message: Start Taking a ... 11 Women who take folic acid supplements for ... cut their risk of having a premature baby by ... online journal, PLOS Medicine.The study links pre-conceptional folate supplementation ...
... Announces Positive Top Line Results of its Clinical Study ... Mass., May 11 Logical Therapeutics, Inc (Logical), a ... treat diseases associated with inflammation, today announced that Peter ... has been elected to the Company,s Board of Directors. ...
Cached Medicine Technology:Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth 2Logical Therapeutics Appoints Peter A. Lankau as CEO and Director 2Logical Therapeutics Appoints Peter A. Lankau as CEO and Director 3Logical Therapeutics Appoints Peter A. Lankau as CEO and Director 4
Inquire...
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
... and Hypergamma Controls are designed ... agarose gels or Sebia's ... unique control manufacturing process preserves ... other serum components, presenting a ...
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Medicine Products: